stockrow
Friday 6 November 2026
Export PLSE’s income statement to Excel — free account
Pulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
53.15
3.91
−6.85%
Follow PLSE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
Altman Z-Score |
31.41 | — | — | (6.18) | 4.11 | — | — | — | — | — |
P/S ratio |
1,526.95 | — | — | 60.44 | 0.00 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(10.11) | — | — | (12.64) | (16.58) | — | — | — | — | — |
P/FCF ratio |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
(62.71) | — | — | (11.72) | (32.63) | — | — | — | — | — |
P/B ratio |
11.47 | — | — | 0.00 | 11.60 | — | — | — | — | — |
Price to Tangible BV |
11.97 | — | — | 0.00 | 13.95 | — | — | — | — | — |
EV/Sales |
1,502.31 | — | — | 63.54 | 0.00 | — | — | — | — | — |
EV/EBITDA |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
(16.82) | — | — | (2.09) | (7.33) | — | — | — | — | — |
EV/FCF |
(16.72) | — | — | (2.07) | (7.28) | — | — | — | — | — |
Quick Ratio |
10.22 | 11.74 | 6.61 | 10.22 | 3.37 | 2.70 | 5.70 | 19.17 | 17.20 | 16.14 |
Current Ratio |
10.53 | 11.88 | 6.76 | 10.39 | 4.30 | 2.95 | 5.92 | 19.42 | 17.39 | 16.40 |
Net Debt/EBITDA |
1.06 | 2.14 | 1.05 | (0.08) | 0.28 | 0.19 | 0.39 | 1.62 | 1.54 | 1.86 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 84.64% | 20.74% | 27.50% | 16.03% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (29.32) | 0.32 | 0.50 | 0.22 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.74 | 0.68 | 0.78 | 0.80 | 0.85 | 0.71 | 0.73 | 0.64 | 0.43 | 0.85 |
Capex/Depreciation |
(0.31) | (0.11) | (0.10) | (0.30) | (0.38) | (0.40) | (0.95) | (0.24) | (2.48) | (0.08) |
| (74.45%) | (67.31%) | (200.47%) | (349.89%) | (217.33%) | (185.90%) | (96.78%) | (66.85%) | (71.72%) | (48.86%) | |
| (64.12%) | (55.93%) | (61.61%) | (88.56%) | (133.26%) | (119.82%) | (83.46%) | (62.34%) | (67.16%) | (46.84%) | |
ROIC |
0.00% | 0.00% | 0.00% | (1,434.21%) | (214.91%) | (226.70%) | (248.56%) | (351.46%) | (203.55%) | (67.29%) |
Return on Tangible Assets |
(95.08%) | (48.47%) | (105.14%) | (100.65%) | (208.22%) | (289.29%) | (191.64%) | (63.18%) | (65.83%) | (59.62%) |
Average Days of Receivables |
285.74 | — | — | 0.00 | 15.70 | — | — | — | — | — |
Research and Development Expense of Revenue |
12,777.43% | 0.00% | 0.00% | 2,977.00% | 2,019.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9,151.14% | 0.00% | 0.00% | 3,710.57% | 2,385.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.04 | 0.03 | 0.08 | 0.07 | 0.11 | 0.16 | 0.18 | 0.11 | 0.17 | 0.35 |
Share Based Compensation of Revenue |
6,130.57% | 0.00% | 0.00% | 741.57% | 1,029.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.08 | — | — | (0.19) | 0.04 | — | — | — | — | — |
Graham Number |
0.00 | — | — | 1.62 | 0.00 | — | — | — | — | — |
Earnings Yield |
(7.87%) | — | — | (64.00%) | (15.46%) | — | — | — | — | — |
Free Cash Flow Yield |
(5.88%) | — | — | (50.81%) | (13.17%) | — | — | — | — | — |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.02 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.80) | (0.62) | (0.66) | (1.39) | (1.93) | (1.52) | (1.65) | (1.40) | (0.75) | (0.73) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.02) | (0.02) | (0.03) | (0.02) | (0.17) | (0.01) |
Free Cash Flow per Share |
(0.81) | (0.62) | (0.67) | (1.40) | (1.95) | (1.54) | (1.68) | (1.42) | (0.92) | (0.74) |
Cash per Share |
1.20 | 2.02 | 0.89 | 1.80 | 1.02 | 0.88 | 1.22 | 3.49 | 2.58 | 1.49 |
Shareholders Equity per Share |
1.20 | 1.97 | 0.89 | (0.07) | 1.28 | 0.98 | 1.48 | 3.88 | 3.12 | 2.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.20 | 1.97 | 0.89 | (0.07) | 1.28 | 0.98 | 1.48 | 3.88 | 3.12 | 2.30 |
Free Cash Flow |
(54.46) | (36.47) | (33.16) | (47.41) | (54.53) | (35.81) | (34.79) | (24.17) | (13.64) | (8.11) |
Working Capital |
75.50 | 109.39 | 38.62 | 56.17 | 28.11 | 14.75 | 21.94 | 57.25 | 36.27 | 15.65 |
Capital Expenditures |
(0.33) | (0.12) | (0.12) | (0.40) | (0.44) | (0.44) | (0.61) | (0.28) | (2.55) | (0.06) |
Net Current Asset Value |
69.54 | 101.85 | 30.53 | (17.98) | 18.07 | 3.94 | 15.23 | 56.06 | 34.66 | 15.65 |
EV/EBIT |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.96 | 0.00 | 0.00 | 0.57 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.02 | 1.02 | 0.79 | 0.69 | 0.47 | 0.44 | 0.25 | 0.54 | 0.40 | 2.41 |
Cash ROIC |
(33.74%) | (15.66%) | (37.38%) | (37.99%) | (72.18%) | (65.43%) | (55.36%) | (19.20%) | (16.22%) | (19.46%) |
Accounts Receivable Turnover |
2.09 | — | — | 0.00 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.24 | 0.00 | 0.00 | 5.34 | 0.85 | 0.60 | 0.72 | 1.28 | 1.91 | 2.88 |
Inventory Turnover |
0.18 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
1,880.53 | 0.00 | 0.00 | 48.07 | 538.60 | 572.33 | 617.67 | 354.41 | 285.14 | 127.44 |
Days of Inventory on Hand |
92.10 | — | — | 0.00 | 1,080.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.17 | — | — | — | — | — | — | — | — | — |
Average Payables |
2.23 | 1.75 | 1.70 | 2.24 | 2.31 | 1.84 | 1.62 | 1.03 | 0.52 | 0.26 |
Average Inventory |
2.98 | — | — | — | — | — | — | — | — | — |
Average Assets |
113.50 | 95.81 | 68.52 | 66.06 | 47.77 | 41.60 | 56.28 | 60.23 | 38.07 | 20.32 |
Average Common Equity |
97.76 | 79.61 | 21.06 | 16.72 | 29.29 | 26.82 | 48.54 | 56.16 | 35.65 | 19.48 |
Columns are period end dates · fundamentals updated 5 Nov 2026